News

Pharmaceutical company Regeneron buying 23andMe for $256 million
Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data ...
Daily Voice Somerset County, NJ on MSN2h
Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data
Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...
Genetic data will be safeguarded with 23andMe sale, drugmaker vows
The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...
23andMe bought by Regeneron in court auction
How exactly 23andMe will shake out after the Regeneron purchase is to be seen. The company has taken a dramatic fall in ...
23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...
Struggling DNA testing firm 23andMe to be bought for $256m
The DNA testing firm 23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m ...
23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private
Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as ...
Biotech company Regeneron buying 23andMe for $256 million
The proposed transaction with Regeneron includes 23andMe’s personal genome service and total health and research services.
Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.